BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron d…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Ownership 2026-05-28
Lockhard, Peter Douglas sold +$1k
Insider trading – 2026-05-28
1 insider · −$1k net
Ownership 2026-05-26
Lockhard, Peter Douglas sold +$17k
Insider trading – 2026-05-26
1 insider · −$17k net
News 2026-05-19
BioSyent Announces Health Canada Approval of Thyconvi™ (levothyroxine oral solution)
News release - English.pdf
Results 2026-05-14 Returns
BioSyent Declares Second Quarter 2026 Dividend
News release - English.pdf
Results 2026-05-14
Interim MD&A - English.pdf
Results 2026-05-14
BioSyent Releases Financial Results for First Quarter 2026
News release - English.pdf
Results 2026-05-14
Interim financial statements/report – English.pdf
Ownership 2026-05-06
Goehrum, Rene sold +$65k
Insider trading – 2026-05-06
1 insider · −$65k net
Results 2026-04-23
Annual report - English.pdf
Ownership 2026-04-02
Moothan, Ramesh sold +$11k
Insider trading – 2026-04-02
1 insider · −$11k net
News 2026-04-01
BioSyent is Canada's Top-Ranked Iron Supplement for 11 Consecutive Years
News release - English.pdf
Ownership 2026-03-30
Wilson, Kevin sold +$21k
Insider trading – 2026-03-30
1 insider · −$21k net
Ownership 2026-03-26
Goehrum, Rene sold +$2.4M
Insider trading – 2026-03-26
1 insider · −$2.4M net
Ownership 2026-03-20
Ashrafi, Seyed Ahmad bought +$13k
Insider trading – 2026-03-20
1 insider · +$13k net
Results 2026-03-19 Financials
Annual MD&A - English.pdf
Results 2026-03-19 Financials
Audited annual financial statements – English.pdf
Results 2026-03-19
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025
News release - English.pdf
Ownership 2026-03-17
4 insiders · +$20k net
Insider trading – 2026-03-17
4 insiders · +$20k net
Ownership 2026-03-16
Elford, Sara bought +$1k
Insider trading – 2026-03-16
1 insider · +$1k net
Transactions 2026-03-02 M&A
BioSyent Announces Closing of the Acquisition of Oral Science Inc.
News release - English.pdf
Transactions 2026-02-18
Other material contracts - English.pdf
Transactions 2026-02-18 M&A
BioSyent Inc. Enters into Agreement to Acquire Oral Science Inc.
Material change report - English.pdf
Transactions 2026-02-09 M&A
BioSyent to Acquire Oral Science Inc.
News release - English.pdf
Results 2026-01-29 Returns
BioSyent Declares First Quarter 2026 Dividend
News release - English.pdf
Results 2025-12-15 Returns
BioSyent Inc. Announces Normal Course Issuer Bid
Material change report - English.pdf
Results 2025-12-15 Returns
BioSyent Announces Renewal of Normal Course Issuer Bid
News release - English.pdf
Results 2025-11-20 Financials
Interim MD&A - English.pdf
Results 2025-11-20 Financials
Interim financial statements/report – English.pdf
Results 2025-11-20
BioSyent Releases Financial Results for Q3 and YTD 2025
News release - English.pdf
Results 2025-11-20 Returns
BioSyent Declares Fourth Quarter 2025 Dividend
News release - English.pdf
News 2025-11-13
News release - English.pdf
News 2025-08-21
News release - English.pdf
Results 2025-08-21 Financials
Interim MD&A - English.pdf
Results 2025-08-21 Financials
Interim financial statements/report – English.pdf
News 2025-08-21
News release - English.pdf
News 2025-08-14
News release - English.pdf
Ownership 2025-06-17
Wilson, Kevin sold +$12k
Insider trading – 2025-06-17
1 insider · −$12k net
Ownership 2025-06-06
Wilson, Kevin sold +$78k
Insider trading – 2025-06-06
1 insider · −$78k net
Ownership 2025-05-26
Wilson, Kevin sold +$7k
Insider trading – 2025-05-26
1 insider · −$7k net
Ownership 2025-05-23
Lockhard, Peter Douglas sold +$4k
Insider trading – 2025-05-23
1 insider · −$4k net
Ownership 2025-05-22
Lockhard, Peter Douglas sold +$2k
Insider trading – 2025-05-22
1 insider · −$2k net
Ownership 2025-04-04
Goehrum, Rene bought +$29k
Insider trading – 2025-04-04
1 insider · +$29k net
Ownership 2025-04-01
Raghubir, Sharan sold +$28k
Insider trading – 2025-04-01
1 insider · −$28k net
Ownership 2025-03-23
Raghubir, Sharan bought +$10k
Insider trading – 2025-03-23
1 insider · +$10k net
Ownership 2025-03-21
Lockhard, Peter Douglas sold +$450
Insider trading – 2025-03-21
1 insider · −$450 net
Ownership 2025-03-19
Lockhard, Peter Douglas sold +$7k
Insider trading – 2025-03-19
1 insider · −$7k net
Ownership 2025-03-18
Wilson, Kevin bought +$12k
Insider trading – 2025-03-18
1 insider · +$12k net
Ownership 2025-03-13
Arcuri, Joseph bought +$2k
Insider trading – 2025-03-13
1 insider · +$2k net
Ownership 2025-03-11
4 insiders · +$26k net
Insider trading – 2025-03-11
4 insiders · +$26k net
Ownership 2024-12-16
Ashrafi, Seyed Ahmad sold +$11k
Insider trading – 2024-12-16
1 insider · −$11k net
Ownership 2024-11-26
Lockhard, Peter Douglas sold +$7k
Insider trading – 2024-11-26
1 insider · −$7k net
Ownership 2024-10-01
Raghubir, Sharan sold +$23k
Insider trading – 2024-10-01
1 insider · −$23k net
Ownership 2024-09-24
Lockhard, Peter Douglas sold +$7k
Insider trading – 2024-09-24
1 insider · −$7k net
Ownership 2024-09-23
Ashrafi, Seyed Ahmad sold +$86k
Insider trading – 2024-09-23
1 insider · −$86k net
Ownership 2024-06-30
Raghubir, Sharan sold +$4k
Insider trading – 2024-06-30
1 insider · −$4k net
Ownership 2024-06-21
Raghubir, Sharan sold +$55k
Insider trading – 2024-06-21
1 insider · −$55k net
Ownership 2024-06-17
Goehrum, Rene sold +$14k
Insider trading – 2024-06-17
1 insider · −$14k net